Б. Спивак

1.1k total citations
31 papers, 775 citations indexed

About

Б. Спивак is a scholar working on Psychiatry and Mental health, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Б. Спивак has authored 31 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Psychiatry and Mental health, 4 papers in Pharmacology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Б. Спивак's work include Schizophrenia research and treatment (9 papers), Electroconvulsive Therapy Studies (8 papers) and Bipolar Disorder and Treatment (8 papers). Б. Спивак is often cited by papers focused on Schizophrenia research and treatment (9 papers), Electroconvulsive Therapy Studies (8 papers) and Bipolar Disorder and Treatment (8 papers). Б. Спивак collaborates with scholars based in Israel and United States. Б. Спивак's co-authors include Abraham Weizman, Roberto Mester, N Gonen, Moshe Kotler, Daniela Amital, Michael J. Beckman, Leah Fostick, Yaffa Vered, Rachel Maayan and Biana Shtaif and has published in prestigious journals such as American Journal of Psychiatry, The British Journal of Psychiatry and Psychological Medicine.

In The Last Decade

Б. Спивак

28 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Б. Спивак Israel 14 401 149 130 127 110 31 775
Eva Hilger Austria 18 252 0.6× 125 0.8× 147 1.1× 68 0.5× 141 1.3× 35 948
E Frank United States 16 322 0.8× 220 1.5× 204 1.6× 91 0.7× 164 1.5× 17 821
Isabel Martínez‐Gras Spain 15 277 0.7× 94 0.6× 132 1.0× 87 0.7× 146 1.3× 35 725
J Wilmotte Belgium 16 274 0.7× 193 1.3× 167 1.3× 159 1.3× 155 1.4× 47 840
Henri Lôo France 18 506 1.3× 321 2.2× 159 1.2× 61 0.5× 188 1.7× 40 1.0k
Conrad Iyegbe United Kingdom 16 292 0.7× 187 1.3× 239 1.8× 41 0.3× 113 1.0× 33 903
E. R�ther Germany 14 238 0.6× 185 1.2× 82 0.6× 40 0.3× 253 2.3× 20 832
Jaana Föhr Finland 12 207 0.5× 99 0.7× 195 1.5× 104 0.8× 221 2.0× 21 953
Monica Bosi Italy 10 232 0.6× 214 1.4× 96 0.7× 59 0.5× 111 1.0× 22 735
Ali Bozkurt Türkiye 16 163 0.4× 97 0.7× 127 1.0× 204 1.6× 106 1.0× 32 852

Countries citing papers authored by Б. Спивак

Since Specialization
Citations

This map shows the geographic impact of Б. Спивак's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Б. Спивак with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Б. Спивак more than expected).

Fields of papers citing papers by Б. Спивак

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Б. Спивак. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Б. Спивак. The network helps show where Б. Спивак may publish in the future.

Co-authorship network of co-authors of Б. Спивак

This figure shows the co-authorship network connecting the top 25 collaborators of Б. Спивак. A scholar is included among the top collaborators of Б. Спивак based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Б. Спивак. Б. Спивак is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shmulewitz, Dvora, Melanie M. Wall, Efrat Aharonovich, et al.. (2013). Validity of proposed DSM-5 diagnostic criteria for nicotine use disorder: results from 734 Israeli lifetime smokers. Psychological Medicine. 43(10). 2179–2190. 12 indexed citations
2.
Fostick, Leah, et al.. (2010). The economic impact of depression: Resistance or severity?. European Neuropsychopharmacology. 20(10). 671–675. 45 indexed citations
3.
Amital, Daniela, et al.. (2008). Serious life events among resistant and non-resistant MDD patients. Journal of Affective Disorders. 110(3). 260–264. 66 indexed citations
4.
Reznik, Ilya, Rafael Stryjer, Б. Спивак, et al.. (2004). Clozapine in the Treatment of Obsessive-compulsive Symptoms in Schizophrenia Patients: A Case Series Study. Pharmacopsychiatry. 37(2). 52–56. 39 indexed citations
5.
Спивак, Б., Rachel Maayan, Moshe Kotler, et al.. (2000). Elevated circulatory level of GABAA – antagonistic neurosteroids in patients with combat-related post-traumatic stress disorder. Psychological Medicine. 30(5). 1227–1231. 111 indexed citations
6.
Спивак, Б., et al.. (2000). Frequency of neuroleptic malignant syndrome in a large psychiatric hospital in Moscow. European Psychiatry. 15(5). 330–333. 24 indexed citations
7.
Спивак, Б., et al.. (2000). Hemispheric function in disorganized type schizophrenia: performance on the Quality Extinction Test. European Psychiatry. 15(7). 402–406. 2 indexed citations
8.
Leykin, Igor, Б. Спивак, Abraham Weizman, Irun R. Cohen, & Meir Shinitzky. (1999). Elevated Cellular Immune Response to Human Heat-Shock Protein-60 in Schizophrenic Patients. European Archives of Psychiatry and Clinical Neuroscience. 249(5). 238–246. 8 indexed citations
9.
Спивак, Б., Yaffa Vered, Roni Yoran‐Hegesh, et al.. (1999). Circulatory levels of catecholamines, serotonin and lipids in attention deficit hyperactivity diiorder. Acta Psychiatrica Scandinavica. 99(4). 300–304. 77 indexed citations
10.
Спивак, Б., et al.. (1999). The effect of long-term antipsychotic treatment on the body weight of patients suffering from chronic schizophrenia: clozapine versus classical antipsychotic agents. International Clinical Psychopharmacology. 14(4). 229–232. 11 indexed citations
11.
Valevski, Avi, Mohamed O. Radwan, Shay Gur, et al.. (1999). Homicide by schizophrenic patients in Israel. European Psychiatry. 14(2). 89–92. 14 indexed citations
12.
Спивак, Б., Michael M. Segal, Roberto Mester, & Abraham Weizman. (1998). Lateral preference in post-traumatic stress disorder. Psychological Medicine. 28(1). 229–232. 43 indexed citations
13.
Спивак, Б., et al.. (1997). Clozapine Treatment for Neuroleptic-Induced Tardive Dyskinesia, Parkinsonism, and Chronic Akathisia in Schizophrenic Patients. The Journal of Clinical Psychiatry. 58(7). 318–322. 74 indexed citations
14.
Спивак, Б., et al.. (1997). Trihexyphenidyl treatment of clozapine-induced hypersalivation. International Clinical Psychopharmacology. 12(4). 213–216. 43 indexed citations
15.
Спивак, Б., et al.. (1996). Functional hemisphere imbalance in patients with paranoid or disorganized schizophrenia. European Psychiatry. 11(4). 175–179. 1 indexed citations
16.
Спивак, Б., et al.. (1996). Antinuclear autoantibodies in relation to bipolar affective disorder and lithium therapy. European Psychiatry. 11(1). 50–52. 3 indexed citations
17.
Спивак, Б., et al.. (1995). Antinuclear autoantibodies in chronic schizophrenia. Acta Psychiatrica Scandinavica. 92(4). 266–269. 23 indexed citations
18.
Спивак, Б., et al.. (1991). Haloperidol and lithium carbonate treatment did not influence serum immunoglobulin levels in schizophrenic and affective patients. Acta Psychiatrica Scandinavica. 84(3). 225–228. 5 indexed citations
19.
Спивак, Б., et al.. (1990). Neuroleptic malignant syndrome during abrupt reduction of neuroleptic treatment. Acta Psychiatrica Scandinavica. 81(2). 168–169. 30 indexed citations
20.
Sirota, P., et al.. (1989). Neurosyphilis Presenting as Psychiatric Disorders. The British Journal of Psychiatry. 155(4). 559–561. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eva Hilger Breakdown of academic impact, for papers by E Frank Breakdown of academic impact, for papers by Isabel Martínez‐Gras Breakdown of academic impact, for papers by J Wilmotte Breakdown of academic impact, for papers by Henri Lôo Breakdown of academic impact, for papers by Conrad Iyegbe Breakdown of academic impact, for papers by E. R�ther Breakdown of academic impact, for papers by Jaana Föhr Breakdown of academic impact, for papers by Monica Bosi Breakdown of academic impact, for papers by Ali Bozkurt
Rankless by CCL
2026